As North America embraces an expanding cannabis products market with both Canada and the U.S. seeing substantial growth, Australia and New Zealand remain more cautious in their approach to cannabis legalisation. This disparity highlights a complex blend of regulatory, cultural, and economic factors influencing the cannabis industry's integration into mainstream consumer markets.
In North America, cannabis has increasingly been accepted as both a medicinal and recreational substance. The North American market is currently valued at nearly USD$42 billion and is projected to continue growing robustly, with cannabis becoming a significant economic contributor as its more widely accepted in consumer culture. This acceptance is supported by evolving legal frameworks encouraging both entrepreneurial ventures and consumer safety.
Lehua Brands, a California-based cannabis drinks and well-being products manufacturer, recently confirmed the US industry's potential by securing top honours at the California State Fair, winning gold and silver medals for its innovative cannabis infused beverages containing both THC and CBD. This recognition not only highlights the quality and appeal of their products but also marks a significant achievement in the broader acceptance of cannabis.
Source: Lehua Brands - Cannabis infused recreational drinks.
.
Conversely, in Australia and New Zealand, the path to legalization and mainstream acceptance has been more fraught. Despite a relatively high public support for legalisation in some regions, such as South Australia, federal and state laws remain restrictive. In New Zealand, despite a push towards establishing a medical cannabis scheme, a referendum on recreational cannabis failed to pass, reflecting persistent public and political hesitancy.
Both countries face unique challenges that stem partly from concerns about public health and social impacts. In Australia, the medical community plays a pivotal role, with general practitioners acting as gatekeepers for medicinal cannabis access. Their cautious stance, combined with stringent regulations, has slowed the adoption and acceptance of cannabis even in medicinal context.
As well, the indigenous communities in both countries, which have been disproportionately affected by prohibition policies, are cautious about the regulatory models being developed, suggesting a need for more inclusive and culturally sensitive approaches.
Source: Lehua Brands - Cannabis Infused sleep-aid drink.
The Australian and New Zealand markets are also constrained by their smaller population sizes and the current focus on ensuring that any expansion in cannabis use does not exacerbate existing social or health issues. Economic factors, such as the potential for international trade and domestic economic benefits, are seen as promising but are not yet fully realised.
This juxtaposition of North America's rapidly growing cannabis market against the more cautiously conservative, regulated approaches in Australia and New Zealand illustrate the complex, multifaceted nature of cannabis legalisation and its acceptance into mainstream society. As the global perspective on cannabis continues to evolve, both regions offer instructive contrasts in how legalisation can unfold within different societal and regulatory frameworks.
ENDS:
Comments